BioCentury
ARTICLE | Clinical News

Topsalysin: Additional Phase IIa data

July 18, 2016 7:00 AM UTC

Data from an open-label, U.K. Phase IIa trial in 18 patients with localized prostate cancer showed that a single intraprostatic injection of topsalysin led to complete ablation of the targeted tumor w...